Major stock indexes closed lower on Friday, after the week saw a flurry of events, including DeepSeek scare and earnings ...

Research photo from the National Cancer Institute, shared via Unsplash. (NCI Photo) When Luca Foschini, head of Seattle's ...

Stepping into the CCO role, Colin Stanley brings over 25 years of sector experience and a proven track record in business ...

New Jersey-based biotechnology company, Grignard Pure LLC, a leader in developing next-generation indoor air treatment solutions for disease mitigation, indoor air quality and pandemic response, is ...

Learn more about whether Biogen Inc. or Gilead Sciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether Biogen Inc. or Exact Sciences Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The Stevie® Awards have announced two Grand Stevie Award winners in the sixth annual Middle East & North Africa Stevie Awards. These are the top prizes in the competition. Grand Stevie winners will be ...

Biogen (NASDAQ:BIIB) shares experienced a change in market expectations as Cantor Fitzgerald revised the company's price target. The new target has been set at $206.00, a decrease from the previous ...

Sage Therapeutics Inc. sued Biogen Inc. (Friday, the 17th) a week after the biotech giant made an unsolicited offer to acquire the smaller neuroscience company for about $469 million. The lawsuit ...

Biotech investing can be tricky. Often, the drugs that these fledgling companies produce don’t pan out, and shareholders take a drubbing. But at OSE Immunotherapeutics, which aims to prevent ...

New licensing Guidelines issued by the National Institutes of Health at the end of the Biden Administration could harm ...